Related Experiment Videos
Megatrials are based on a methodological mistake
1Department of Psychology, University of Newcastle upon Tyne.
Abstract:
Despite their prestige, megatrials are founded upon a methodological error. This is the assumption that randomization of very large numbers of subjects can compensate for deliberately reduced levels of experimental control, but there is no trade-off between size and rigour. Randomized trials are not a 'gold standard' because no method is intrinsically valid-there are good and bad trials. Interpretation of megatrials is always difficult and requires considerable clinical and scientific knowledge. Three fundamental parameters should be considered when evaluating the applicability of a trial to clinical practice: rigour of design; representativeness of the trial population; and homogeneity of the recruited subjects.
Insights
Megatrials, despite their prestige, may contain methodological errors. Evaluating clinical trial applicability requires considering design rigor, population representativeness, and subject homogeneity, not just large sample sizes.
Area of Science:
- Clinical research methodology
- Evidence-based medicine
Background:
- Megatrials are highly regarded in medical research.
- However, their design may contain inherent methodological flaws.
- The assumption that large sample sizes compensate for reduced experimental control is questioned.
Purpose of the Study:
- To critically evaluate the methodological underpinnings of megatrials.
- To identify key parameters for assessing the clinical applicability of randomized trials.
- To challenge the notion of randomized trials as an infallible 'gold standard'.
Main Methods:
- Analysis of the methodological assumptions in megatrial design.
- Discussion of the relationship between sample size and experimental rigor.
- Identification of critical parameters for trial evaluation.
Main Results:
- Megatrials may be founded on a methodological error: assuming size compensates for reduced control.
- There is no inherent trade-off where larger trials automatically equate to greater rigor.
- The interpretation of megatrials necessitates significant clinical and scientific expertise.
Conclusions:
- Randomized trials are not universally a 'gold standard'; quality varies.
- Applicability to clinical practice depends on design rigor, population representativeness, and subject homogeneity.
- A critical evaluation of these parameters is essential for interpreting megatrial results effectively.